KR20000036184A - 신경계 질환 치료를 위한 벤조피라놀의 용도 - Google Patents
신경계 질환 치료를 위한 벤조피라놀의 용도 Download PDFInfo
- Publication number
- KR20000036184A KR20000036184A KR1019997002238A KR19997002238A KR20000036184A KR 20000036184 A KR20000036184 A KR 20000036184A KR 1019997002238 A KR1019997002238 A KR 1019997002238A KR 19997002238 A KR19997002238 A KR 19997002238A KR 20000036184 A KR20000036184 A KR 20000036184A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- hydrogen
- compound
- amino
- alkoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9619492.3 | 1996-09-18 | ||
GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20000036184A true KR20000036184A (ko) | 2000-06-26 |
Family
ID=10800127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019997002238A KR20000036184A (ko) | 1996-09-18 | 1997-09-15 | 신경계 질환 치료를 위한 벤조피라놀의 용도 |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP0939630B1 (xx) |
JP (1) | JP2001500520A (xx) |
KR (1) | KR20000036184A (xx) |
CN (1) | CN1230885A (xx) |
AP (1) | AP9901473A0 (xx) |
AR (1) | AR008838A1 (xx) |
AT (1) | ATE270102T1 (xx) |
AU (1) | AU730465B2 (xx) |
BG (1) | BG103252A (xx) |
BR (1) | BR9712030A (xx) |
CA (1) | CA2266681A1 (xx) |
DE (1) | DE69729735T2 (xx) |
DZ (1) | DZ2311A1 (xx) |
EA (1) | EA199900306A1 (xx) |
ES (1) | ES2223075T3 (xx) |
GB (1) | GB9619492D0 (xx) |
HU (1) | HUP9904638A3 (xx) |
ID (2) | ID23175A (xx) |
IL (1) | IL128786A0 (xx) |
MA (1) | MA24321A1 (xx) |
NO (1) | NO991292D0 (xx) |
NZ (1) | NZ334271A (xx) |
OA (1) | OA10998A (xx) |
PE (1) | PE109898A1 (xx) |
PL (1) | PL332313A1 (xx) |
SK (1) | SK35199A3 (xx) |
TR (1) | TR199900527T2 (xx) |
UY (1) | UY24717A1 (xx) |
WO (1) | WO1998011890A1 (xx) |
ZA (1) | ZA978359B (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
MX2010013313A (es) * | 2008-06-05 | 2011-05-30 | Minster Res Ltd | Tratamientos novedosos. |
WO2009147441A2 (en) * | 2008-06-05 | 2009-12-10 | Minster Research Limited | Novel treatments |
WO2011067607A1 (en) * | 2009-12-03 | 2011-06-09 | Minster Research Ltd | Treatment of infectious diseases |
CA2774715C (en) | 2009-07-27 | 2018-04-03 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
US20130018091A1 (en) * | 2009-12-03 | 2013-01-17 | Peter Blower | Treatment of allodynia and hyperalgesia |
CN103096977B (zh) | 2010-07-02 | 2017-02-15 | 吉利德科学公司 | 作为离子通道调节剂的稠杂环化合物 |
CA2834164A1 (en) | 2011-05-10 | 2012-11-15 | Gilead Sciences, Inc. | Fused benzoxazinones as ion channel modulators |
NO3175985T3 (xx) | 2011-07-01 | 2018-04-28 | ||
TWI478908B (zh) | 2011-07-01 | 2015-04-01 | Gilead Sciences Inc | 作為離子通道調節劑之稠合雜環化合物 |
CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
DE69524871T2 (de) * | 1994-06-10 | 2002-08-22 | Smithkline Beecham Plc | Benzopyrans und deren verwendung als therapeutische mittel |
GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Application Discontinuation
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Application Discontinuation
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 EP EP97909300A patent/EP0939630B1/en not_active Expired - Lifetime
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292D0/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2001500520A (ja) | 2001-01-16 |
ID23175A (id) | 2000-03-23 |
EA199900306A1 (ru) | 1999-08-26 |
GB9619492D0 (en) | 1996-10-30 |
BG103252A (en) | 1999-09-30 |
DZ2311A1 (fr) | 2002-12-28 |
PL332313A1 (en) | 1999-08-30 |
OA10998A (en) | 2003-03-04 |
HUP9904638A2 (hu) | 2001-05-28 |
BR9712030A (pt) | 1999-08-24 |
AR008838A1 (es) | 2000-02-23 |
EP0939630B1 (en) | 2004-06-30 |
AU730465B2 (en) | 2001-03-08 |
NZ334271A (en) | 2001-03-30 |
DE69729735D1 (de) | 2004-08-05 |
CN1230885A (zh) | 1999-10-06 |
UY24717A1 (es) | 2001-08-27 |
MA24321A1 (fr) | 1998-04-01 |
IL128786A0 (en) | 2000-01-31 |
AU4704797A (en) | 1998-04-14 |
CA2266681A1 (en) | 1998-03-26 |
HUP9904638A3 (en) | 2001-08-28 |
TR199900527T2 (xx) | 1999-06-21 |
NO991292L (no) | 1999-03-17 |
SK35199A3 (en) | 2000-07-11 |
DE69729735T2 (de) | 2005-07-14 |
ZA978359B (en) | 1999-03-17 |
ID19542A (id) | 1998-07-23 |
AP9901473A0 (en) | 1999-03-31 |
EP0939630A1 (en) | 1999-09-08 |
ES2223075T3 (es) | 2005-02-16 |
ATE270102T1 (de) | 2004-07-15 |
WO1998011890A1 (en) | 1998-03-26 |
NO991292D0 (no) | 1999-03-17 |
PE109898A1 (es) | 1999-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100481254B1 (ko) | 미르타자핀과하나이상의선택적인세로토닌재흡수저해제를포함하는약학조성물 | |
CN103687853B (zh) | 新型双氨基喹啉化合物及其制备的药物组合物和它们的用途 | |
KR20000036184A (ko) | 신경계 질환 치료를 위한 벤조피라놀의 용도 | |
EP1901733A1 (en) | Use of huperzine for disorders | |
CA2616177C (en) | Imidazolylalkyl-pyridines for the treatment of a sleep disorder | |
MX2010013312A (es) | Tratamientos novedoos. | |
CA2720983A1 (en) | Method of treating melanoma | |
KR20010052487A (ko) | 신경계 질환 및 탈모 치료에 사용되는 아자-헤테로고리화합물 | |
KR101405823B1 (ko) | 녹내장의 치료 및 예방을 위한 약제 조성물 | |
US5962523A (en) | Methods of using butyric acid derivatives to protect against hair loss | |
US5502049A (en) | Use of phenothiazine derivatives in the treatment of ischaemia and/or hypoxia | |
EP0813873B1 (en) | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors | |
US6492415B2 (en) | Use of benzopyranols to treat neurological disorders | |
NZ222806A (en) | Antihypertensive medicaments | |
MX2012006352A (es) | Tratamiento de alodinia e hiperalgesia. | |
JPH0525167A (ja) | 緑内障の治療に有用な置換ベンゼン誘導体 | |
US5886021A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis | |
CZ92999A3 (cs) | Farmaceutický prostředek pro léčbu a/nebo profylaxi neurologických poruch a použití sloučenin obsahujících fosfor k výrobě léčiva | |
WO2001007023A2 (en) | Azetidine compounds in cns and eye diseases | |
EP1196166A1 (en) | Azetidine carboxamide derivatives for the treatment of cns disorders | |
JP2003504396A (ja) | マクロライド化合物の新規用途 | |
KR20040091638A (ko) | 아자-스피로 화합물 | |
GB2413322A (en) | Nefopam analogues | |
HUT72589A (en) | Benzopyron analogues for the treatment of anxiety, mania, depression or withdrawal symptoms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |